Celltrion reported KRW3.4T in Current Liabilities for its fiscal quarter ending in March of 2025.


Current Liabilities Change Date
Alaunos Therapeutics USD 4K 822K Oct/2024
Avita Medical AUD 20.16M 6.37M Dec/2024
Celltrion KRW 3.4T 216.25B Mar/2025
Dianthus Therapeutics USD 20.09M 1.64M Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
IQVIA Holdings USD 7.57B 393M Jun/2025
Moderna USD 1.57B 32M Jun/2025
Organon & Co USD 2.8B 181M Jun/2025
Revvity USD 671.81M 23.63M Jun/2025
Tectonic Therapeutic USD 11.36M 250K Jun/2025
Viatris USD 7.13B 1.41B Jun/2025
Xeris Pharmaceuticals USD 95.17M 5.27M Jun/2025